Health Care Weekly: InnovAge Settles Probes of Business Practices Sparked by Capitol Forum Report; CMS Finalizes Phosphate Binder Rate; House Panel Asks CBO to Revisit No Surprises Act; CVS Bumps Dexcom from Formularies; Health Plan Marketers Face FTC Scrutiny; FDA Floats Approval Pathway for Gene Editing; Medicaid Work Requirements Rule Unlawful, Court Says
The Health Care Weekly is a timely analysis of competition developments, policy changes and other updates that may affect medical and pharmaceutical markets. In this edition: • InnovAge settles...
Nov 04, 2026
Read Now >


